• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.07% Nasdaq Down 0.51%

    Zogenix, Inc. (ZGNX)

    -NasdaqGM
    1.37 Down 0.01(0.72%) 11:26AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.38
    Open:1.40
    Bid:1.35 x 3900
    Ask:1.36 x 6800
    1y Target Est:2.75
    Beta:1.12
    Earnings Date:Mar 3 - Mar 9 (Est.)
    Day's Range:1.34 - 1.40
    52wk Range:1.07 - 5.19
    Volume:1,138,613
    Avg Vol (3m):2,217,260
    Market Cap:209.66M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ZGNXDown 0.72%209.66M
    AZNUp 0.76%90.37B
    GSKDown 0.12%108.03B
    PFEDown 1.10%199.10B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.66
    Quarterly EPS Est (Dec-14) :-0.11
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):-0.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback